MRI detector for implantable medical device

• US 7,509,167 B2
• Filed: 02/16/2006
• Issued: 03/24/2009
• Est. Priority Date: 02/16/2006
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Stessman, Nicholas J.
• Primary Examiner(s): Evanisko; George R
• Assistant Examiner(s): HOLMES, REX R
• Application Number:
  US11/276,159
• Publication Number:
  US 20070191914A1
• Time in Patent Office: 1,132 Days
• Field of Search: 607/9
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents

Abstract

An implantable medical device with an inductive switching regulator having an inductor with a ferromagnetic core is described. The device incorporates a core saturation detector for detecting saturation in the inductor core indicating the presence of a magnetic field such as produced by an MRI scan. The device is configured to alter its behavior when core saturation is detected such as by entering an MRI mode that may include cessation of therapy, fixed-rate bradycardia pacing, and/or disablement of tachyarrhythmia therapy.

Claims

1. An implantable medical device, comprising:

an inductive switching regulator having an inductor with a ferromagnetic core;

a core saturation detector for detecting saturation in the inductor core of the inductive switching regulator indicating the presence of a magnetic field;

wherein the inductive switching regulator alternately stores and discharges energy in an inductor in a two-phase power conversion cycle, the power conversion phases designated as fill and dump phases, respectively, such that the inductor current increases until a predetermined peak current value is reached during the fill phase and decreases to zero or other predetermined value during the dump phase;

circuitry for measuring the duration of at least part of a power conversion cycle;

wherein the core saturation detector detects core saturation if the duration of the measured duration of the power conversion cycle exceeds a specified threshold value; and

,

circuitry for altering the behavior of the device when core saturation is detected.

2. The device of claim 1 further comprising:

sensing circuitry for receiving electrogram signals that reflect the electrical activity of the heart;

therapy circuitry for delivering electrical stimulation the heart;

control circuitry for controlling the delivery of electrical stimulation to the heart in a normal operating mode; and

,

wherein the control circuitry is configured to alter the behavior of the device by causing the device to enter a non-sensing MRI mode upon detection of core saturation.

3. The device of claim 2 wherein the MRI mode includes cessation of the delivery of electrical stimulation to the heart.

4. The device of claim 2 wherein the MRI mode includes fixed-rate bradycardia pacing.

5. The device of claim 2 wherein the MRI mode includes disablement of delivery of tachyarrhythmia therapy by the therapy circuitry.

6. The device of claim 2 wherein:

the circuitry for measuring the duration of at least part of a power conversion cycle is configured to measure the duration of the fill phase during a power conversion cycle; and

,

wherein the core saturation detector detects core saturation if the duration of the fill phase exceeds a specified threshold value.

7. The device of claim 1 wherein:

the circuitry for measuring the duration of at least part of a power conversion cycle is configured to measure the duration of the dump phase during a power conversion cycle; and

,

wherein the core saturation detector detects core saturation if the duration of the dump phase exceeds a specified threshold value.

8. The device of claim 1 wherein:

the circuitry for measuring the duration of at least part of a power conversion cycle is configured to measure the entire duration of a power conversion cycle; and

,

wherein the core saturation detector detects core saturation if the duration of the power conversion cycle exceeds a specified threshold value.

10. The device of claim 2 wherein the device is configured to revert to the normal operating mode when core saturation is no longer detected.

9. An implantable medical device, comprising:

an inductive switching regulator having an inductor with a ferromagnetic core, wherein the inductive switching regulator is configured to operate in a clocked frequency or pulse width modulation control mode;

a core saturation detector for detecting saturation in the inductor core of the inductive switching regulator indicating the presence of a magnetic field;

circuitry for altering the behavior of the device when core saturation is detected;

circuitry for measuring the peak inductor current during a power conversion cycle; and

,

wherein the core saturation detector detects core saturation if the peak inductor current exceeds a specified threshold value.

11. A method for operating an implantable medical device incorporating an inductive switching regulator having an inductor with a ferromagnetic core, comprising:

operating the inductive switching regulator to alternately store and discharge energy in the inductor in a two-phase power conversion cycle, the power conversion phases designated as fill and dump phases, respectively, such that the inductor current increases until a predetermined peak current value is reached during the fill phase and decreases to zero or other predetermined value during the dump phase,

detecting saturation in the inductor core of the inductive switching regulator indicating the presence of a magnetic field by measuring the duration of at least part of a power conversion cycle and detecting core saturation if the duration of the measured duration of the power conversion cycle exceeds a specified threshold value; and

,

altering the behavior of the device when core saturation is detected.

12. The method of claim 11 further comprising:

receiving electro gram signals that reflect the electrical activity of the heart;

delivering therapy in the form of electrical stimulation to the heart in accordance with a normal operating mode;

altering the behavior of the device by entering a non-sensing MRI mode upon detection of core saturation.

13. The method of claim 12 wherein the MRI mode includes cessation of the delivery of electrical stimulation to the heart.

14. The method of claim 12 wherein the MRI mode includes fixed-rate bradycardia pacing.

15. The method of claim 12 wherein the MRI mode includes disablement of delivery of tachyarrhythmia therapy.

16. The method of claim 11 further comprising:

measuring the duration of the fill phase during a power conversion cycle; and

,

detecting core saturation if the duration of the fill phase exceeds a specified threshold value.

17. The method of claim 11 further comprising:

measuring the duration of the dump phase during a power conversion cycle; and

,

detecting core saturation if the duration of the dump phase exceeds a specified threshold value.

18. The method of claim 11 further comprising:

measuring the duration of a power conversion cycle; and

,

detecting core saturation if the duration of the power conversion cycle exceeds a specified threshold value.

20. The method of claim 12 further comprising reverting to the normal operating mode when core saturation is no longer detected.

19. A method for operating an implantable medical device incorporating an inductive switching regulator having an inductor with a ferromagnetic core, comprising:

operating the inductive switching regulator in a clocked frequency modulation or pulse width modulation control mode;

detecting saturation in the inductor core of the inductive switching regulator indicating the presence of a magnetic field by measuring the peak inductor current during a power conversion cycle and detecting core saturation if the peak inductor current exceeds a specified threshold value; and

altering the behavior of the device when core saturation is detected.